HeartWorks is a non-profit focused on funding development of cell based products to cure congenital heart disease. HeartWorks was created in June, 2020 to accelerate and expand the product development pioneered by the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS), founded at Mayo Clinic in 2010. The HLHS program has formed a nationwide research consortium and developed cell-based therapeutics to treat CHD, some of which are currently in clinical trials. We build heart muscle that will be tested in many different shapes and sizes of CHD with a single purpose to repair the defect.